Circulating tumor cells and their role in prostate cancer

Circulating tumor cells and their role in prostate cancer

Circulating tumor cells (CTC) have become an important biomarker in patients with advanced prostate cancer. CTC count has been demonstrated to be a prognostic factor for overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC). In localized prostate cancer, a clear c...

Full description

Bibliographic Details
Main Authors: Moritz Maas, Miriam Hegemann, Steffen Rausch, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Asian Journal of Andrology
Subjects:
AR-V7; biomarker; cell-free DNA; cfDNA; circulating tumor cells; ctDNA; liquid biopsy; prostate cancer
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=24;epage=31;aulast=Maas

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=1;spage=24;epage=31;aulast=Maas

Similar Items